We can ban drugs approved by DCGI: Centre to Delhi High Court
The government reserved the right to ban drugs in spite of DCGI’s approval as it was conducting a legislative exercise detached from the regulator's past decisions.

The court, meanwhile, has extended by nearly two more weeks the stay on the ban of the brands using these combinations, said the lawyer, who is representing a large pharmaceutical firm in the hearings. Justice RS Endlaw asked Additional Solicitor General Sanjay Jain, the government's counsel, what guided the Centre's decision to ban the drugs with approval from the Drug Controller General of India ( DCGI).
The central government reserved the right to ban these drugs in spite of DCGI’s approval as it was conducting a legislative exercise detached from the regulator's past decisions and approvals, Jain responded, according to the lawyer.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.